[1]
2026. Metabolic syndrome and cardiovascular risk in patients with breast cancer undergoing adjuvant endocrine therapy. Electronic Journal Collection Health. 26, 3 (Mar. 2026), e23208. DOI:https://doi.org/10.25248/reas.e23208.2026.